Literature DB >> 15454275

MnSOD antisense treatment and exercise-induced protection against arrhythmias.

Karyn L Hamilton1, John C Quindry, Joel P French, Jess Staib, Jeffrey Hughes, Jawahar L Mehta, Scott K Powers.   

Abstract

Exercise provides protection against ischemia-reperfusion (I-R)-induced arrhythmias, myocardial stunning, and infarction. An exercise-induced increase in myocardial manganese superoxide dismutase (MnSOD) activity has been reported to be vital for protection against infarction. However, whether MnSOD is essential for exercise-induced protection against ventricular arrhythmias is unknown. We determined the effects of preventing the exercise-induced increase in MnSOD activity on arrhythmias during I-R resulting in myocardial stunning. Male rats remained sedentary or were subjected to successive bouts of endurance exercise. During in vivo myocardial I-R, the incidence of arrhythmias was significantly lower in the exercise-trained rats than in the sedentary rats as evidenced by the arrhythmia. When exercised rats were pretreated with antisense oligonucleotides directed against MnSOD, protection from arrhythmias was attenuated. Moreover, I-R resulted in significant increases in nitro-tyrosine (NT) in the sedentary group. Exercise abolished this I-R-induced NT formation but this protection was unchanged by antisense treatment. Protein carbonyls were increased by I-R, but neither exercise nor antisense treatment impacted carbonyl formation. These data demonstrate that an exercise-induced increase in MnSOD activity is important for protection against arrhythmias. The mechanism by which MnSOD provides protection does not appear to be linked to protein nitrosylation or oxidation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15454275     DOI: 10.1016/j.freeradbiomed.2004.07.025

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  26 in total

1.  Short term training attenuates opening of the mitochondrial permeability transition pore without affecting myocardial function following ischemia-reperfusion.

Authors:  Marc Ciminelli; Alexis Ascah; Karine Bourduas; Yan Burelle
Journal:  Mol Cell Biochem       Date:  2006-05-23       Impact factor: 3.396

Review 2.  Mechanisms of exercise-induced cardioprotection.

Authors:  Scott K Powers; Ashley J Smuder; Andreas N Kavazis; John C Quindry
Journal:  Physiology (Bethesda)       Date:  2014-01

Review 3.  Exercise preconditioning of the myocardium.

Authors:  Andreas N Kavazis
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

Review 4.  Mitochondrial therapeutics for cardioprotection.

Authors:  Raquel S Carreira; Pamela Lee; Roberta A Gottlieb
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 5.  Exercise: Teaching myocytes new tricks.

Authors:  Scott K Powers
Journal:  J Appl Physiol (1985)       Date:  2017-06-01

6.  Mitochondrial KATP channel inhibition blunts arrhythmia protection in ischemic exercised hearts.

Authors:  John C Quindry; Lindsey Schreiber; Peter Hosick; Jenna Wrieden; J Megan Irwin; Emily Hoyt
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-30       Impact factor: 4.733

7.  Exercise preconditioning attenuates pressure overload-induced pathological cardiac hypertrophy.

Authors:  Tongyi Xu; Hao Tang; Ben Zhang; Chengliang Cai; Xiaohong Liu; Qingqi Han; Liangjian Zou
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

Review 8.  Subcellular Energetics and Metabolism: Potential Therapeutic Applications.

Authors:  Robert H Thiele
Journal:  Anesth Analg       Date:  2017-06       Impact factor: 5.108

9.  Evaluation of arrhythmia scoring systems and exercise-induced cardioprotection.

Authors:  Lindsey E Miller; Peter A Hosick; Jenna Wrieden; Emily Hoyt; John C Quindry
Journal:  Med Sci Sports Exerc       Date:  2012-03       Impact factor: 5.411

10.  Exercise-induced protection against myocardial apoptosis and necrosis: MnSOD, calcium-handling proteins, and calpain.

Authors:  Joel P French; Karyn L Hamilton; John C Quindry; Youngil Lee; Patrick A Upchurch; Scott K Powers
Journal:  FASEB J       Date:  2008-04-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.